Live Breaking News & Updates on Pataday Once Daily Relief

Stay updated with breaking news from Pataday once daily relief. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Dr Reddy's lab enters into a licensing agreement for OTC ophthalmic product for US market - Jammu Kashmir Latest News | Tourism

Hyderabad, July 30: Dr Reddy’s Laboratories Limited said that it has entered into a licensing agreement with Princeton, New Jersey based Slayback Pharma LLC to acquire rights in Slayback’s Brimonidine Tartrate Ophthalmic Solution 0.025 percent, the private label equivalent of Lumify in U.S. Lumify is an Over-The-counter (OTC) eye drop that can be used to relieve redness of the eye due to minor eye irritations. The agreement also provides Dr. Reddy’s exclusive rights to the product outside the U.S, Hyderabad-based […] ....

United States , Andhra Pradesh , New Jersey , Marc Kikuchi , Slayback Pharma , Dr Reddy Laboratories , Laboratories Limited , Brimonidine Tartrate Ophthalmic Solution , Chief Executive Officer , North America Generics , Pataday Once Daily Relief , Pataday Twice Daily Relief ,

Dr. Reddy's Laboratories enters into a licensing agreement with Slayback Pharma to obtain exclusive rights in the first-to-file ANDA for the private label version of Lumify in the U.S.

Dr. Reddy's Laboratories enters into a licensing agreement with Slayback Pharma to obtain exclusive rights in the first-to-file ANDA for the private label version of Lumify in the U.S.
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

United States , Ajay Singh , Marc Kikuchi , Reddy Laboratories Ltd , Chief Executive Officer , North America Generics , Pataday Once Daily Relief , Pataday Twice Daily Relief , Once Daily Relief ,